세계의 약물 남용 검사 시장 : 제품 및 서비스별, 샘플 유형별, 최종 사용자별 - 기회 분석과 산업 예측(2024-2033년)

Drug Abuse Testing Market By Product and Service , By Sample type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,248,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,465,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

전 세계 약물 남용 검사 시장 규모는 2023년에 500만 달러로 평가되었으며 2024년부터 2033년까지 연평균 6%의 성장률을 기록할 것으로 예상되며 2033년에는 880만 달러에 달할 것으로 예측되고 있습니다.

약물 남용 검사는 사람의 체내에서 불법 약물, 처방약 또는 대사 산물의 존재를 확인하는 과학적 과정을 말합니다. 이 검사는 소변, 혈액, 타액, 모발, 땀과 같은 생물학적 시료를 사용하여 개인이 특정 물질을 사용했는지 여부를 결정합니다. 약물 남용 검사는 직장 안전, 임상 진단, 법적 조사 및 재활 프로그램에서 중요한 도구입니다.

세계의 약물 남용 질환의 놀랄만한 증가는 약물 남용 검사 시장의 주요 촉진요인입니다. 유엔 약물 범죄 사무소(UNODC) 보고서에 따르면 2022년에는 15-64세의 2억 8,400만 명 이상이 적어도 한 번은 약물을 사용했으며, 광범위한 검사의 필요성이 부각되고 있습니다. 또한 음주운전이나 약물 관련 범죄 등 약물 남용이 치안에 미치는 영향에 대한 인식이 높아져 법집행기관과 교통 모니터링 프로그램에서 정기적인 약물 검사 수요를 끌어올리고 있습니다. 또한, 세계 약물의 가용성 증가가 시장 성장에 크게 기여하고 있습니다. 예를 들어, ECCDDA(European Monitoring Centre for Drugs and Drug Addiction)는 2024년에 유럽에서는 다양한 약물이 이전과는 비교할 수 없을 정도로 접근하기 쉬워졌으며, 대마초가 가장 일반적으로 사용되는 불법 약물이며 코카인이 그 뒤를 잇고 있다고 보고했습니다. 또한 비용면에서 효율적이고 사용하기 쉬운 가정용 약물 검사 키트를 사용할 수 있게 됨으로써 개인과 가정에서의 이용이 증가하여 시장 확대에 기여하고 있습니다. 그러나 액체 크로마토그래피 질량분석법과 같은 고급 약물 검사 기술은 비쌉니다. 따라서 특히 자원에 제약이 있는 의료 환경에서는 배포가 제한될 수 있습니다. 사회적 판단과 차별에 대한 두려움은 개인이 자발적으로 약물 검사를 받는 것을 방해할 수 있고, 이는 검사 프로그램의 성장에 더욱 영향을 미칠 가능성도 있습니다. 그와는 반대로, 현장 의료 진단 기기, 개량형 면역 측정법, 질량 분석 기술 등의 기술 혁신에 의해 약물 검사의 정확성, 신속성, 접근성이 향상되고 있습니다. 이러한 발전은 예측 기간 동안 세계 시장 확대에 유익한 기회를 제공할 것으로 기대됩니다.

약물 남용 검사 시장은 제품 및 서비스, 샘플 유형, 최종 사용자 및 지역으로 구분됩니다. 제품 및 서비스별 시장은 분석장치, 신속검사장치, 소모품, 실험실 서비스로 나뉩니다. 분석 장치는 또한 면역 측정 분석기, 크로마토그래피 분석기, 호흡 분석기로 구분됩니다. 신속 검사 장치는 소변 검사 장치와 구강 유체 검사 장치로 세분됩니다. 소모품은 분석 키트, 샘플 채취 컵, 캘리브레이터 컨트롤 등으로 분류됩니다. 샘플 유형별 시장은 소변, 구강액, 호흡, 모발 및 기타 샘플로 분류됩니다. 최종 사용자별 시장은 직장,학교, 형사 사법 시스템,법 집행 기관, 연구실, 병원으로 세분화됩니다. 지역별 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카에서 나뉩니다.

주요 조사 결과

제품 및 서비스별 시장에서는 분석장치가 2023년 가장 높은 시장 점유율을 차지했습니다.

샘플 유형별 시장에서는 소변 부문이 2023년에 가장 높은 성장을 보였습니다.

최종 사용자별 시장에서는 직장,학교 부문이 2023년에 최대 점유율을 획득했습니다.

지역별 시장에서는 북미가 2023년 최대 시장 점유율을 차지했고 예측 기간 동안 빠른 속도로 성장할 것으로 예측됩니다.

본 보고서에서 가능한 보고서 커스터마이즈(추가 비용과 타임라인에 관해서는 판매 담당에게 연락해 주세요)

• 규제 가이드라인
• 고객의 관심에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 : 시장 규모 및 예측
• 평균 판매 가격 분석/가격대 분석
• 교차 부문 분석 : 시장 규모와 예측
• 기업 프로파일 확장 목록
• 과거 시장 데이터
• 주요 기업의 상세(소재지, 연락처 상세, 공급자/벤더 네트워크 등을 포함한 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회

제4장 약물 남용 검사 시장 : 제품 및 서비스별

• 시장 개요
• 분석장치
  • 면역 측정 분석 장치
  • 크로마토그래피 분석 장치
  • 호흡분석장치
• 신속검사장치
  • 소변검사장치
  • 구강액 검사 장치
• 소모품
  • 분석 키트
  • 샘플 채취 컵
  • 캘리브레이터 컨트롤
  • 기타
• 실험실 서비스

제5장 약물 남용 검사 시장 : 샘플 유형별

• 시장 개요
• 소변
• 구강액
• 호흡
• 모발
• 기타 샘플

제6장 약물 남용 검사 시장 : 최종 사용자별

• 시장 개요
• 직장,학교
• 형사 사법 시스템,법 집행 기관
• 연구실
• 병원

제7장 약물 남용 검사 시장 :지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 약물 남용 검사 시장
  • 캐나다의 약물 남용 검사 시장
  • 멕시코의 약물 남용 검사 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 약물 남용 검사 시장
  • 독일의 약물 남용 검사 시장
  • 이탈리아의 약물 남용 검사 시장
  • 스페인의 약물 남용 검사 시장
  • 영국의 약물 남용 검사 시장
  • 기타 유럽의 약물 남용 검사 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 약물 남용 검사 시장
  • 일본의 약물 남용 검사 시장
  • 인도의 약물 남용 검사 시장
  • 한국의 약물 남용 검사 시장
  • 호주 약물 남용 검사 시장
  • 기타 아시아태평양의 약물 남용 검사 시장
• 라틴아메리카· 중동,아프리카
  • 주요 시장 동향과 기회
  • 브라질의 약물 남용 검사 시장
  • 남아프리카의 약물 남용 검사 시장
  • 사우디아라비아의 약물 남용 검사 시장
  • 기타 라틴아메리카· 중동· 아프리카의 약물 남용 검사 시장

제8장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝:2023년

제9장 기업 프로파일

• The Dragerwerk AG And Co. KGaA
• Abbott Laboratories
• F. HOFFMANN-LA ROCHE AG
• Bio Rad Laboratories, Inc.
• Siemens AG
• Thermo Fisher Scientific, Inc.
• Laboratory Corporation Of America Holdings
• Danaher Corporation
• Quest Diagnostics Incorporated
• Express Diagnostics International Inc.

SHW

영문 목차

영문목차

The drug abuse testing market was valued at $5.0 million in 2023, and is projected to reach $8.8 million by 2033, growing at a CAGR of 6% from 2024 to 2033.

Drug abuse testing refers to the scientific process of identifying the presence of illicit drugs, prescription medications, or their metabolites in a person's system. This testing is conducted using biological specimens such as urine, blood, saliva, hair, or sweat to determine if an individual has used specific substances. Drug abuse testing is a critical tool in workplace safety, clinical diagnostics, legal investigations, and rehabilitation programs.

Alarming increase in prevalence of substance abuse disorders worldwide is a primary driver of the drug abuse testing market. According to a report by the United Nations Office on Drugs and Crime (UNODC), over 284 million people aged 15-64 used drugs at least once in 2022, underscoring the need for widespread testing. In addition, rise in awareness about the impact of substance abuse on public safety, such as impaired driving and drug-related crimes, has driven the demand for routine drug testing in law enforcement and traffic monitoring programs. Moreover, increase in global drug availability significantly contributes toward the market growth. For instance, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in 2024 that Europe is experiencing unprecedented availability of various drugs, with cannabis being the most commonly used illicit drug, followed by cocaine. Furthermore, the availability of cost-effective and easy-to-use home drug testing kits has seen increased adoption among individuals and families, contributing to market expansion. However, sophisticated drug testing techniques, such as liquid chromatography-mass spectrometry, are expensive. This can limit their adoption, especially in resource-constrained healthcare settings. Fear of societal judgment and discrimination may deter individuals from undergoing drug testing voluntarily, further affecting the growth of testing programs. On the contrary, technological innovations, such as point-of-care testing devices, improved immunoassays, and mass spectrometry techniques, have made drug testing more accurate, faster, and accessible. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The drug abuse testing market is segmented into product & service, sample type, end user, and region. By product & service, the market is divided into analyzers, rapid testing devices, consumables and laboratory services. The analyzers segment is further segmented into immunoassay analyzers, chromatography analyzers and breath analyzers. The rapid testing devices is subdivided into urine testing devices and oral fluid testing devices. The consumables segment is further categorized into assay kits, sample collection cups, calibrators & controls, and others. Depending on sample type, the market is segregated into urine, oral fluid, breath, hair, and other samples. By end user, it is fragmented into workplaces & schools, criminal justice systems & law enforcement agencies, research laboratories, and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product & service, the analyzers segment dominated the market share in 2023.

On the basis of sample type, the urine segment exhibit the highest growth in 2023.

Depending on end user segment, the workplaces & schools segment garnered the largest share in 2023.

Region wise, North America held the largest market share in 2023, and is projected to grow at a high pace during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global drug abuse testing market include The Dragerwerk AG & Co. KGaA, Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Average Selling Price Analysis / Price Point Analysis
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product And Service

• Analyzers
  • Immunoassay analyzers
  • Chromatography analyzers
  • Breath analyzers
• Rapid Testing Devices
  • Urine testing devices
  • Oral fluid testing devices
• Consumables
  • Assay kits
  • Sample collection cups
  • Calibrators and controls
  • Others
• Laboratory Services

By Sample Type

• Urine
• Oral Fluid
• Breath
• Hair
• Other Samples

By End User

• Workplaces and Schools
• Criminal Justice Systems and Law Enforcement Agencies
• Research laboratories
• Hospitals

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• The Dragerwerk AG & Co. KGaA
• Abbott Laboratories
• F. HOFFMANN-LA ROCHE AG
• Bio Rad Laboratories, Inc.
• Siemens AG
• Thermo Fisher Scientific, Inc.
• Laboratory Corporation of America Holdings
• Danaher Corporation
• Quest Diagnostics Incorporated
• Express Diagnostics International Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT AND SERVICE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Product And Service
• 4.2. Analyzers
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
  • 4.2.5. Immunoassay analyzers
    • 4.2.5.1. Market Size and Forecast
  • 4.2.6. Chromatography analyzers
    • 4.2.6.1. Market Size and Forecast
  • 4.2.7. Breath analyzers
    • 4.2.7.1. Market Size and Forecast
• 4.3. Rapid Testing Devices
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
  • 4.3.5. Urine testing devices
    • 4.3.5.1. Market Size and Forecast
  • 4.3.6. Oral fluid testing devices
    • 4.3.6.1. Market Size and Forecast
• 4.4. Consumables
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
  • 4.4.5. Assay kits
    • 4.4.5.1. Market Size and Forecast
  • 4.4.6. Sample collection cups
    • 4.4.6.1. Market Size and Forecast
  • 4.4.7. Calibrators and controls
    • 4.4.7.1. Market Size and Forecast
  • 4.4.8. Others
    • 4.4.8.1. Market Size and Forecast
• 4.5. Laboratory Services
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Sample Type
• 5.2. Urine
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Oral Fluid
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Breath
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Hair
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country
• 5.6. Other Samples
  • 5.6.1. Key Market Trends, Growth Factors and Opportunities
  • 5.6.2. Market Size and Forecast, By Region
  • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Workplaces And Schools
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Criminal Justice Systems And Law Enforcement Agencies
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Research Laboratories
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country
• 6.5. Hospitals
  • 6.5.1. Key Market Trends, Growth Factors and Opportunities
  • 6.5.2. Market Size and Forecast, By Region
  • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Product And Service
  • 7.2.3. Market Size and Forecast, By Sample Type
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Drug Abuse Testing Market
    • 7.2.6.1. Market Size and Forecast, By Product And Service
    • 7.2.6.2. Market Size and Forecast, By Sample Type
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Drug Abuse Testing Market
    • 7.2.7.1. Market Size and Forecast, By Product And Service
    • 7.2.7.2. Market Size and Forecast, By Sample Type
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Drug Abuse Testing Market
    • 7.2.8.1. Market Size and Forecast, By Product And Service
    • 7.2.8.2. Market Size and Forecast, By Sample Type
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Product And Service
  • 7.3.3. Market Size and Forecast, By Sample Type
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Drug Abuse Testing Market
    • 7.3.6.1. Market Size and Forecast, By Product And Service
    • 7.3.6.2. Market Size and Forecast, By Sample Type
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Drug Abuse Testing Market
    • 7.3.7.1. Market Size and Forecast, By Product And Service
    • 7.3.7.2. Market Size and Forecast, By Sample Type
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Drug Abuse Testing Market
    • 7.3.8.1. Market Size and Forecast, By Product And Service
    • 7.3.8.2. Market Size and Forecast, By Sample Type
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Drug Abuse Testing Market
    • 7.3.9.1. Market Size and Forecast, By Product And Service
    • 7.3.9.2. Market Size and Forecast, By Sample Type
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Drug Abuse Testing Market
    • 7.3.10.1. Market Size and Forecast, By Product And Service
    • 7.3.10.2. Market Size and Forecast, By Sample Type
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest Of Europe Drug Abuse Testing Market
    • 7.3.11.1. Market Size and Forecast, By Product And Service
    • 7.3.11.2. Market Size and Forecast, By Sample Type
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Product And Service
  • 7.4.3. Market Size and Forecast, By Sample Type
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Drug Abuse Testing Market
    • 7.4.6.1. Market Size and Forecast, By Product And Service
    • 7.4.6.2. Market Size and Forecast, By Sample Type
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Drug Abuse Testing Market
    • 7.4.7.1. Market Size and Forecast, By Product And Service
    • 7.4.7.2. Market Size and Forecast, By Sample Type
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Drug Abuse Testing Market
    • 7.4.8.1. Market Size and Forecast, By Product And Service
    • 7.4.8.2. Market Size and Forecast, By Sample Type
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Drug Abuse Testing Market
    • 7.4.9.1. Market Size and Forecast, By Product And Service
    • 7.4.9.2. Market Size and Forecast, By Sample Type
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Drug Abuse Testing Market
    • 7.4.10.1. Market Size and Forecast, By Product And Service
    • 7.4.10.2. Market Size and Forecast, By Sample Type
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Drug Abuse Testing Market
    • 7.4.11.1. Market Size and Forecast, By Product And Service
    • 7.4.11.2. Market Size and Forecast, By Sample Type
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Product And Service
  • 7.5.3. Market Size and Forecast, By Sample Type
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Drug Abuse Testing Market
    • 7.5.6.1. Market Size and Forecast, By Product And Service
    • 7.5.6.2. Market Size and Forecast, By Sample Type
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Drug Abuse Testing Market
    • 7.5.7.1. Market Size and Forecast, By Product And Service
    • 7.5.7.2. Market Size and Forecast, By Sample Type
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Drug Abuse Testing Market
    • 7.5.8.1. Market Size and Forecast, By Product And Service
    • 7.5.8.2. Market Size and Forecast, By Sample Type
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Drug Abuse Testing Market
    • 7.5.9.1. Market Size and Forecast, By Product And Service
    • 7.5.9.2. Market Size and Forecast, By Sample Type
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping Of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. The Dragerwerk AG And Co. KGaA
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Abbott Laboratories
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. F. HOFFMANN-LA ROCHE AG
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Bio Rad Laboratories, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Siemens AG
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Thermo Fisher Scientific, Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Laboratory Corporation Of America Holdings
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Danaher Corporation
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Quest Diagnostics Incorporated
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Express Diagnostics International Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료